Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

AVEO Pharmaceuticals presents new anti-GDF-15 MAbs

July 18, 2014

Previously identified RIP1 kinase inhibitor potentially useful for necroptosis

Jan. 24, 2014

P2X1 receptor revealed as a target in transfusion-related acute lung injury

Aug. 6, 2013

Novel autotaxin inhibitors reported by Pfizer

May 23, 2013

Model of hyperoxic injury shows adaptive changes against infection and ROS

Jan. 31, 2013

Novel vitamin E derivative suppresses oxidative stress in animal models of traumatic injury

Jan. 25, 2013

New vaccines for birch pollen allergy presented by Teknologian Tutkimuskeskus

Nov. 20, 2012

Pacific Therapeutics reports encouraging phase I results with combination treatment for fibrosis

Nov. 15, 2012

Researchers at Reata Pharmaceuticals prepare new NO production inhibitors

Oct. 16, 2012

Biotie Therapies describes novel SSAO inhibitors

Oct. 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 12, 2025.
Could restricting diversity efforts stall women’s health research?
BioWorld
Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash against diversity, equity and...
Alkermes’ alixorexton hits endpoints in narcolepsy phase II
BioWorld
Alkermes plc’s placebo-controlled phase II study of alixorexton in treating narcolepsy type 2 (NT2) hit its dual primary endpoints, producing statistically...
Pazdur ‘optimal fit’ to lead FDA’s CDER
BioWorld
In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to...